news paper icon

Analyzed News

BRIEF-Zimmer Biomet announces FDA approval of knee osteoarthritis vaccine

* Zimmer Biomet announces FDA approval of expanded 26-week efficacy claim for gel-one cross-linked hyaluronate for treatment of pain associated with knee osteoarthritis Source text for Eikon:... [Source]

Publication Date:

Origin: reuters.com

Category: governmentFilingsNews

Topics: approval, announces, Biomet, Eikon, osteoarthritis Source, associated, for treatment, hyaluronate, cross-linked, gel-one, claim, 26-week efficacy, expanded, Zimmer, vaccine, osteoarthritis, BRIEF-Zimmer

Source: http://feeds.reuters.com/~r/reuters/governmentfilingsNews/~3/GyqDRqHenEc/idUSASB0AY2F

Related Articles